tiprankstipranks
Serina Therapeutics (SER)
NYSE MKT:SER
Holding SER?
Track your performance easily

Serina Therapeutics (SER) Financial Statements

185 Followers

Serina Therapeutics Financial Overview

Serina Therapeutics's market cap is currently ―. The company's EPS TTM is $-11.078; its P/E ratio is -0.48; Serina Therapeutics is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue$ 51.00K$ 5.00K$ 56.00K$ 7.00K$ 30.00K
Gross Profit$ 51.00K$ 5.00K$ 55.00K$ 7.00K$ 30.00K
EBIT$ 5.42M$ -9.34M$ -3.47M$ -1.89M$ -2.19M
EBITDA$ 5.48M$ -9.29M$ -3.32M$ -936.00K$ -1.09M
Net Income Common Stockholders$ 5.20M$ -9.44M$ -3.46M$ 808.00K$ 1.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.06M$ 8.71M$ 345.00K$ 261.00K$ 280.00K
Total Assets$ 10.71M$ 10.86M$ 11.96M$ 12.28M$ 12.53M
Total Debt$ 11.71M$ 11.08M$ 4.37M$ 33.01M$ 30.05M
Net Debt$ 5.65M$ 2.38M$ 4.02M$ 32.75M$ 29.77M
Total Liabilities$ 27.10M$ 15.16M$ 6.61M$ 34.34M$ 32.54M
Stockholders Equity$ -16.36M$ -4.31M$ 5.47M$ -22.18M$ -19.91M
Cash Flow-
Free Cash Flow$ -8.00M$ -1.61M$ -2.05M$ -1.18M$ -709.00K
Operating Cash Flow$ -8.00M$ -1.60M$ -2.05M$ -864.00K$ -709.00K
Investing Cash Flow-$ -14.00K-$ -315.00K$ -10.00M
Financing Cash Flow$ 5.37M$ 2.73M$ 2.00M$ -11.00K$ 10.09M
Currency in USD

Serina Therapeutics Earnings and Revenue History

Serina Therapeutics Debt to Assets

Serina Therapeutics Cash Flow

Serina Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis